<DOC>
	<DOCNO>NCT00860197</DOCNO>
	<brief_summary>This study ass whether coffee consumption : - increase immune response - decrease inflammatory status</brief_summary>
	<brief_title>Immune Benefits Coffee</brief_title>
	<detailed_description>Epidemiological study suggest coffee consumption associate protective effect several type chronic disease . Recent data show certain coffee component may possess anti-inflammatory immune-enhancing property . Low-grade inflammation poor capacity immune response highly prevalent elderly subject . The purpose study evaluate whether coffee consumption improve immune inflammatory status healthy elderly subject . To sort role antioxidant , test 2 different soluble coffee , i.e . fully torrefied coffee partially torrefied coffee .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<criteria>Healthy , selfsufficient , freeliving Chilean elderly Having ability comprehend procedure study Having obtain his/her inform consent verbal write information Subjects drinking 2 cup coffee per day Subjects rapidly deteriorate health status enrolment study Subjects terminal acute disease , unstable health status Subjects chronic disease : chronic respiratory illness ; chronic disease pulmonary cardiovascular system ( include asthma ) ; chronic metabolic disease ( diabetes ) ; chronic renal disease , organ failure Subjects serious neurological disorder , include dementia ( MMSE &lt; 20 ) Alzheimer 's disease Subjects experience rapid weight loss , chronic diarrhea ( loose stool , 3 time daily ) , Crohn 's ( IBD ) Subjects gastrointestinal problem Subjects hospitalization plan study Subjects receive antibiotic treatment last 3 month prior begin study Subjects colonoscopy perform last 3 month prior begin study Subjects immune deficiency disease ( e.g . HIV infection ) Subjects history allergy especially egg protein , egg , shellfish antibiotic polymyxin neomycin Subjects receive medication may influence immune system ( i.e . corticosteroid , immunosuppressor immunomodulators , antimicrobial ) Subjects receive vaccination last 15 day prior baseline Subjects expect noncompliant Subjects currently participate participate another clinical trial last 3 month prior begin study Subjects participate another research study involve type medication relate study</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Coffee</keyword>
	<keyword>Elderly</keyword>
	<keyword>Immune response</keyword>
	<keyword>Inflammatory status</keyword>
</DOC>